SEB Concept Biotechnology - Klasse D (EUR)
LU0118405827
SEB Concept Biotechnology - Klasse D (EUR)/ LU0118405827 /
NAV02/10/2024 |
Chg.+0.5790 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
108.9560EUR |
+0.53% |
paying dividend |
Equity
Worldwide
|
SEB IM ▶ |
Stratégie d'investissement
The fund aims to increase the value of your investment over time and to outperform its benchmark.
The fund is actively managed and invests in stocks globally, primarily in the biotech sector. Investment decisions are based on in-depth (fundamental) analysis. The focus is on companies' business models, earning capacity, management and market positions. The return is determined by how much the fund's holdings increase or decrease in value during your holding period.
Objectif d'investissement
The fund aims to increase the value of your investment over time and to outperform its benchmark.
Opérations
Type de rendement: |
paying dividend |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Biotechnology |
Benchmark: |
Nasdaq Biotechnology Index |
Début de l'exercice: |
01/01 |
Dernière distribution: |
23/05/2024 |
Banque dépositaire: |
Skandinaviska Enskilda Banken AB, Lux |
Domicile: |
Luxembourg |
Permission de distribution: |
Germany, Luxembourg, Czech Republic |
Gestionnaire du fonds: |
Angelica Fatouros |
Actif net: |
134.3 Mio.
EUR
|
Date de lancement: |
16/10/2000 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
0.00% |
Frais d'administration max.: |
1.50% |
Investissement minimum: |
- EUR |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
SEB IM |
Adresse: |
Stephanstraße 14 - 16, 60313, Frankfurt am Main |
Pays: |
Germany |
Internet: |
seb.de/asset-management
|
Pays
United States of America |
|
76.07% |
United Kingdom |
|
7.42% |
Cash |
|
3.68% |
Sweden |
|
3.03% |
Netherlands |
|
2.63% |
Denmark |
|
2.32% |
Bermuda |
|
1.53% |
Ireland |
|
1.40% |
Canada |
|
1.02% |
Cayman Islands |
|
0.90% |
Branches
Pharma/Biotechnology |
|
91.78% |
Healthcare services |
|
3.79% |
Cash |
|
3.68% |
Healthcare appliances |
|
0.75% |